Induction outcome as a function of treatment presence or absence of DiOC2(3) efflux modulated by PSC-833 in vitro in patients with pretreatment samples studied for MDR
| . | Efflux positive (n = 43) . | Efflux negative (n = 23) . | Total (n = 66) . | P . |
|---|---|---|---|---|
| ADE | ||||
| CR | 9 (41%) | 10 (91%) | 19 (58%) | .03 |
| NR | 9 (41%) | 1 (9%) | 10 (30%) | |
| Death | 4 (18%) | 0 (0%) | 4 (12%) | |
| Total | 22 | 11 | 33 | |
| ADEP | ||||
| CR | 10 (48%) | 6 (50%) | 16 (48%) | 1.0 |
| NR | 4 (19%) | 2 (17%) | 6 (18%) | |
| Death | 7 (33%) | 4 (33%) | 11 (33%) | |
| Total | 21 | 12 | 33 |
| . | Efflux positive (n = 43) . | Efflux negative (n = 23) . | Total (n = 66) . | P . |
|---|---|---|---|---|
| ADE | ||||
| CR | 9 (41%) | 10 (91%) | 19 (58%) | .03 |
| NR | 9 (41%) | 1 (9%) | 10 (30%) | |
| Death | 4 (18%) | 0 (0%) | 4 (12%) | |
| Total | 22 | 11 | 33 | |
| ADEP | ||||
| CR | 10 (48%) | 6 (50%) | 16 (48%) | 1.0 |
| NR | 4 (19%) | 2 (17%) | 6 (18%) | |
| Death | 7 (33%) | 4 (33%) | 11 (33%) | |
| Total | 21 | 12 | 33 |
NR indicates alive, with no response.